Clinical Trial Update: Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial [Phase 2]

View source ↗

Summary

The MICABO-ALS trial is a Phase 2 study aimed at boosting mitochondrial capacity in amyotrophic lateral sclerosis and is currently recruiting, with Dallas VA Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Dallas VA Medical Center | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: RECRUITING